A-HeFT: Old dog, new endothelial tricks

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

In conclusion, reduced nitric oxide bioactivity contributes to cardiac and vascular remodeling. Nitric-oxide-enhancing therapy can slow cardiac and vascular remodeling. African-Americans with heart failure exhibit nitric oxide deficiency and a dramatic benefit from nitric-oxide-enhancing therapy. The potential benefit of this therapy in other groups with heart failure and in other vascular remodeling disease processes requires further study.

Original languageEnglish (US)
Pages (from-to)366-368
Number of pages3
JournalTexas Heart Institute Journal
Volume32
Issue number3
StatePublished - Sep 23 2005

Fingerprint

Nitric Oxide
Dogs
Heart Failure
Vascular Diseases
African Americans
Therapeutics
Vascular Remodeling

Cite this

A-HeFT : Old dog, new endothelial tricks. / Cohn, Jay N.

In: Texas Heart Institute Journal, Vol. 32, No. 3, 23.09.2005, p. 366-368.

Research output: Contribution to journalArticle

@article{a488cf28f43d47e7a0b955f03a0a023c,
title = "A-HeFT: Old dog, new endothelial tricks",
abstract = "In conclusion, reduced nitric oxide bioactivity contributes to cardiac and vascular remodeling. Nitric-oxide-enhancing therapy can slow cardiac and vascular remodeling. African-Americans with heart failure exhibit nitric oxide deficiency and a dramatic benefit from nitric-oxide-enhancing therapy. The potential benefit of this therapy in other groups with heart failure and in other vascular remodeling disease processes requires further study.",
author = "Cohn, {Jay N}",
year = "2005",
month = "9",
day = "23",
language = "English (US)",
volume = "32",
pages = "366--368",
journal = "Texas Heart Institute Journal",
issn = "0730-2347",
publisher = "Texas Heart Institute",
number = "3",

}

TY - JOUR

T1 - A-HeFT

T2 - Old dog, new endothelial tricks

AU - Cohn, Jay N

PY - 2005/9/23

Y1 - 2005/9/23

N2 - In conclusion, reduced nitric oxide bioactivity contributes to cardiac and vascular remodeling. Nitric-oxide-enhancing therapy can slow cardiac and vascular remodeling. African-Americans with heart failure exhibit nitric oxide deficiency and a dramatic benefit from nitric-oxide-enhancing therapy. The potential benefit of this therapy in other groups with heart failure and in other vascular remodeling disease processes requires further study.

AB - In conclusion, reduced nitric oxide bioactivity contributes to cardiac and vascular remodeling. Nitric-oxide-enhancing therapy can slow cardiac and vascular remodeling. African-Americans with heart failure exhibit nitric oxide deficiency and a dramatic benefit from nitric-oxide-enhancing therapy. The potential benefit of this therapy in other groups with heart failure and in other vascular remodeling disease processes requires further study.

UR - http://www.scopus.com/inward/record.url?scp=24944457344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944457344&partnerID=8YFLogxK

M3 - Article

C2 - 16392220

AN - SCOPUS:24944457344

VL - 32

SP - 366

EP - 368

JO - Texas Heart Institute Journal

JF - Texas Heart Institute Journal

SN - 0730-2347

IS - 3

ER -